Bayer is a leading global company in the life sciences sector, operating with a deep commitment to human health, food security, advancing quality of life, and reducing gaps in access to medical care. Its worldview combines scientific innovation with social responsibility, with the goal of ensuring that advanced medical solutions reach the populations that need them most. In Israel, this commitment is expressed through collaborations with social organizations, making essential medications accessible, and assisting patients facing economic and systemic barriers.
On this occasion, I would like to express our deep appreciation for the important partnership with the Haverim L'Refuah organization. This collaboration enables us to provide real solutions to patients who need medications and assistance with co-payment financing, as well as support in maximizing their rights with the HMO's exceptions committees. Haverim L'Refuah serves as a central address and a beacon of light for many patients, and operates with an open approach to creative and innovative collaborations to strengthen pharmaceutical security in Israel. For the Bayer Israel team, this partnership provides meaning and a sense of mission.
With best regards,
Doron Shalit,
CEO, Bayer Israel
